相关实验视频

Updated: Jul 2, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

431

177 Lu-微球选择性动脉内放射性核素疗法:一种简单且生物相容的永久微粒种植物,用于不可切除的肝细胞癌

Jaya Shukla1, Sejal Chopra1, Komalpreet Kaur1

  • 1From the Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh.

Clinical nuclear medicine
|February 20, 2024
PubMed
概括

使用177Lu微球的选择性动脉内放射性核素治疗 (SIRT) 显示出治疗中级肝细胞癌 (HCC) 的前景. 这项试点研究表明有效的瘤向和保留,表明潜在的新治疗选择.

更多相关视频

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.6K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.5K

相关概念视频